VBI Vaccines Valuation
| VBIV Stock | USD 0.59 0.02 3.28% |
VBI Vaccines is fairly valued. VBI Vaccines has a current Real Value of $0.59 per share. The regular price of the entity is $0.59. Our model measures the value of VBI Vaccines from examining the entity fundamentals such as Return On Equity of -2.59, return on asset of -0.29, and Shares Outstanding of 28.43 M as well as evaluating its technical indicators and probability of bankruptcy. In general, most investors recommend buying undervalued stocks and disposing overvalued stocks since, at some point future time, asset prices and their ongoing real values will draw towards each other. Key fundamental drivers impacting VBI Vaccines' valuation include:
Price Book 0.8206 | Enterprise Value 46.7 M | Enterprise Value Ebitda (0.32) | Price Sales 2.0214 | Enterprise Value Revenue 4.1349 |
Fairly Valued
Today
Please note that VBI Vaccines' price fluctuation is out of control at this time. Calculation of the real value of VBI Vaccines is based on 3 months time horizon. Increasing VBI Vaccines' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for VBI Vaccines is useful when determining the fair value of the VBI stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of VBI Vaccines. Since VBI Vaccines is currently traded on the exchange, buyers and sellers on that exchange determine the market value of VBI Stock. However, VBI Vaccines' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.59 | Real 0.59 | Target 4.0 | Hype 0.61 |
The real value of VBI Stock, also known as its intrinsic value, is the underlying worth of VBI Vaccines Company, which is reflected in its stock price. It is based on VBI Vaccines' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of VBI Vaccines' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence VBI Vaccines' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of VBI Vaccines helps investors to forecast how VBI stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of VBI Vaccines more accurately as focusing exclusively on VBI Vaccines' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use VBI Vaccines' intrinsic value based on its ongoing forecasts of VBI Vaccines' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against VBI Vaccines' closest peers. When choosing an evaluation method for VBI Vaccines, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
VBI Vaccines Investments |
|
VBI Valuation Drivers Correlation
Many accounts on the financial statements of VBI Vaccines are highly interrelated and sometimes correlated. Consequently, when conducting VBI's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of VBI
Click cells to compare fundamentals
VBI Valuation Trend
Knowing VBI Vaccines' actual value is paramount for traders to make sound investment determinations. VBI Vaccines' real value is not only important for the investor to make better decisions but also for a more accurate overall view of VBI Vaccines' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both VBI Vaccines' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
VBI Market Cap
VBI Vaccines is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is at this time estimated at about 18.55 Billion. VBI Vaccines adds roughly 17.3 Million in market capitalization claiming only tiny portion of equities under Health Care industry.VBI Vaccines Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining VBI Vaccines's current stock value. Our valuation model uses many indicators to compare VBI Vaccines value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across VBI Vaccines competition to find correlations between indicators driving VBI Vaccines's intrinsic value. More Info.VBI Vaccines is rated below average in price to earning category among related companies. It is rated below average in price to book category among related companies . Price To Book Ratio is likely to drop to 0.66 in 2024. Comparative valuation analysis is a catch-all model that can be used if you cannot value VBI Vaccines by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for VBI Vaccines' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the VBI Vaccines' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates VBI Vaccines' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in VBI Vaccines and how it compares across the competition.
About VBI Vaccines Valuation
The stock valuation mechanism determines the current worth of VBI Vaccines on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of VBI Vaccines. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of VBI Vaccines based exclusively on its fundamental and basic technical indicators. By analyzing VBI Vaccines's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of VBI Vaccines's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of VBI Vaccines. We calculate exposure to VBI Vaccines's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to VBI Vaccines's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -5.8 M | -5.5 M | |
| Pretax Profit Margin | (10.69) | (11.23) | |
| Operating Profit Margin | (6.37) | (6.69) | |
| Net Loss | (10.69) | (11.23) | |
| Gross Profit Margin | (0.67) | (0.70) |
8 Steps to conduct VBI Vaccines' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates VBI Vaccines' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct VBI Vaccines' valuation analysis, follow these 8 steps:- Gather financial information: Obtain VBI Vaccines' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine VBI Vaccines' revenue streams: Identify VBI Vaccines' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research VBI Vaccines' industry and market trends, including the size of the market, growth rate, and competition.
- Establish VBI Vaccines' growth potential: Evaluate VBI Vaccines' management, business model, and growth potential.
- Determine VBI Vaccines' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate VBI Vaccines' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
VBI Vaccines Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as VBI Vaccines does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 15.6 M |
VBI Vaccines Current Valuation Indicators
Valuation refers to the process of determining the present value of VBI Vaccines and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value VBI we look at many different elements of the entity such as VBI's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. VBI Vaccines' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final VBI Vaccines' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as VBI Vaccines, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use VBI Vaccines' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes VBI Vaccines' worth.When determining whether VBI Vaccines is a strong investment it is important to analyze VBI Vaccines' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact VBI Vaccines' future performance. For an informed investment choice regarding VBI Stock, refer to the following important reports: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VBI Vaccines. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for VBI Stock analysis
When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Transaction History View history of all your transactions and understand their impact on performance |
Is VBI Vaccines' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VBI Vaccines. If investors know VBI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VBI Vaccines listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.03) | Revenue Per Share 0.558 | Quarterly Revenue Growth 1.911 | Return On Assets (0.29) | Return On Equity (2.59) |
The market value of VBI Vaccines is measured differently than its book value, which is the value of VBI that is recorded on the company's balance sheet. Investors also form their own opinion of VBI Vaccines' value that differs from its market value or its book value, called intrinsic value, which is VBI Vaccines' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VBI Vaccines' market value can be influenced by many factors that don't directly affect VBI Vaccines' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VBI Vaccines' value and its price as these two are different measures arrived at by different means. Investors typically determine if VBI Vaccines is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VBI Vaccines' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.